Table 3 Virus reactivation had no... | American Society of Hematology

Table 3

Virus reactivation had no influence on the classification factor

SampleID	PatID	Virus	Days/HSCT	aGvHD development	CF
14292	2225	CMV	32	NA	−0.773
14283	2225	CMV	180	NA	−0.498
14378	2401	CMV	14	NA	0.751
14375	2401	CMV	62	NA	−0.434
15751	2401	CMV	80	NA	0.049
14412	2715	CMV	125	38	−1.1
14441	2718	CMV	43	NA	0.247
14465	2725	CMV	62	25	−0.297
14575	2890	CMV	34	15	−0.557
14642	3023	CMV	47	NA	0.190
14640	3023	CMV	54	NA	−0.238
15278	3203	CMV	47	32	−0.326
15488	3203	CMV	60	32	−0.338
17182	3203	CMV	95	32	0.107
17183	3203	CMV	122	32	−0.758
16629	3203	CMV	129	32	−0.33
16630	3203	CMV	136	32	−0.328
16628	3203	CMV	143	32	−0.69
17184	3203	CMV	150	32	−0.474
14753	3263	CMV	−1	53	0.728
14751	3263	CMV	19	53	0.657
15452	3340	CMV	53	34	0.676
17149	2038	EBV	357	NA	−0.133
15486	2250	EBV	303	NA	−0.443
15718	2250	EBV	331	NA	−0.724
14447	2719	EBV	120	48	−1.266
17173	2890	EBV	248	15	−0.887
15719	3049	EBV	159	29	0.555
17174	3049	EBV	166	29	−0.009
17175	3049	EBV	173	29	−0.034
16125	3049	EBV	179	29	0.319
17176	3049	EBV	186	29	0.365
16625	3049	EBV	200	29	−0.044
17177	3049	EBV	214	29	0.056
14673	3052	EBV	32	NA	−0.074
14687	3065	EBV	31	52	0.558
15450	3264	EBV	59	NA	−0.763
16360	3264	EBV	94	NA	−0.674
15490	3340	EBV	46	34	0.952
15721	3340	EBV	74	34	−0.725
15787	3340	EBV	81	34	−0.577
17186	3340	EBV	136	34	−0.573
15491	3341	EBV	34	NA	−0.3

SampleID	PatID	Virus	Days/HSCT	aGvHD development	CF
14292	2225	CMV	32	NA	−0.773
14283	2225	CMV	180	NA	−0.498
14378	2401	CMV	14	NA	0.751
14375	2401	CMV	62	NA	−0.434
15751	2401	CMV	80	NA	0.049
14412	2715	CMV	125	38	−1.1
14441	2718	CMV	43	NA	0.247
14465	2725	CMV	62	25	−0.297
14575	2890	CMV	34	15	−0.557
14642	3023	CMV	47	NA	0.190
14640	3023	CMV	54	NA	−0.238
15278	3203	CMV	47	32	−0.326
15488	3203	CMV	60	32	−0.338
17182	3203	CMV	95	32	0.107
17183	3203	CMV	122	32	−0.758
16629	3203	CMV	129	32	−0.33
16630	3203	CMV	136	32	−0.328
16628	3203	CMV	143	32	−0.69
17184	3203	CMV	150	32	−0.474
14753	3263	CMV	−1	53	0.728
14751	3263	CMV	19	53	0.657
15452	3340	CMV	53	34	0.676
17149	2038	EBV	357	NA	−0.133
15486	2250	EBV	303	NA	−0.443
15718	2250	EBV	331	NA	−0.724
14447	2719	EBV	120	48	−1.266
17173	2890	EBV	248	15	−0.887
15719	3049	EBV	159	29	0.555
17174	3049	EBV	166	29	−0.009
17175	3049	EBV	173	29	−0.034
16125	3049	EBV	179	29	0.319
17176	3049	EBV	186	29	0.365
16625	3049	EBV	200	29	−0.044
17177	3049	EBV	214	29	0.056
14673	3052	EBV	32	NA	−0.074
14687	3065	EBV	31	52	0.558
15450	3264	EBV	59	NA	−0.763
16360	3264	EBV	94	NA	−0.674
15490	3340	EBV	46	34	0.952
15721	3340	EBV	74	34	−0.725
15787	3340	EBV	81	34	−0.577
17186	3340	EBV	136	34	−0.573
15491	3341	EBV	34	NA	−0.3

Summary of the data of samples taken at the time of viral reactivation in our study set. SampleId, patientID, time of reactivation (days/HSCT), aGvHD development (if appropriate) in days, and the classification factor F are shown.

NA indicates not applicable (no GvHD developed); italic, false positive.

View Large

This Feature Is Available To Subscribers Only